Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial page now presents the study record for neoadjuvant and adjuvant durvalumab in operable urothelial cancer, including its design, participation criteria, measures, locations, and completion status.
    Difference
    55%
    Check dated 2026-11-11T02:20:14.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study record remains blocked by a 403 error.
    Difference
    0.2%
    Check dated 2026-11-04T01:16:17.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the terminology transition appears above the unchanged 403 error page, and the footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:14:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:12:32.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with a generic error message. This indicates an access or server problem affecting the visibility of the study record.
    Difference
    18%
    Check dated 2026-09-23T01:21:47.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0 on the study page, indicating a backend/content update. The update does not modify the study data, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-09-16T00:46:44.000Z thumbnail image

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.